AU674379B2 - Antitussive - Google Patents

Antitussive

Info

Publication number
AU674379B2
AU674379B2 AU57156/94A AU5715694A AU674379B2 AU 674379 B2 AU674379 B2 AU 674379B2 AU 57156/94 A AU57156/94 A AU 57156/94A AU 5715694 A AU5715694 A AU 5715694A AU 674379 B2 AU674379 B2 AU 674379B2
Authority
AU
Australia
Prior art keywords
antitussive
delta
image
acceptable salt
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU57156/94A
Other languages
English (en)
Other versions
AU5715694A (en
Inventor
Takashi Endo
Junzo Kamei
Koji Kawai
Hiroshi Nagase
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Publication of AU5715694A publication Critical patent/AU5715694A/en
Application granted granted Critical
Publication of AU674379B2 publication Critical patent/AU674379B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Linear Motors (AREA)
  • Fats And Perfumes (AREA)
AU57156/94A 1992-12-22 1993-12-22 Antitussive Ceased AU674379B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP34194792 1992-12-22
JP4-341947 1992-12-22
PCT/JP1993/001855 WO1994014445A1 (fr) 1992-12-22 1993-12-22 Antitussif

Publications (2)

Publication Number Publication Date
AU5715694A AU5715694A (en) 1994-07-19
AU674379B2 true AU674379B2 (en) 1996-12-19

Family

ID=18349997

Family Applications (1)

Application Number Title Priority Date Filing Date
AU57156/94A Ceased AU674379B2 (en) 1992-12-22 1993-12-22 Antitussive

Country Status (11)

Country Link
US (1) US5714483A (enExample)
EP (1) EP0636371B1 (enExample)
KR (1) KR950700065A (enExample)
CN (1) CN1071117C (enExample)
AT (1) ATE166229T1 (enExample)
AU (1) AU674379B2 (enExample)
CA (1) CA2130457A1 (enExample)
DE (1) DE69318710T2 (enExample)
NO (1) NO307496B1 (enExample)
TW (1) TW366284B (enExample)
WO (1) WO1994014445A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU712012B2 (en) * 1995-09-26 1999-10-28 Toray Industries, Inc. Indole derivatives and medical application thereof
EP0894799B1 (en) * 1997-01-16 2004-04-07 Toray Industries, Inc. Indolomorphinane derivatives and remedies/preventives for cerebral disorders
EP0998928A4 (en) * 1997-07-09 2002-10-24 Toray Industries Cough medium
KR20020012314A (ko) * 1999-07-19 2002-02-15 히라이 가쯔히꼬 빈뇨 혹은 요실금의 치료 또는 예방제
PL368612A1 (en) * 2001-08-14 2005-04-04 Biotie Therapies Corporation Method of treating alcoholism or alcohol abuse
EP1522542A1 (en) * 2002-07-11 2005-04-13 Toray Industries, Inc. Therapeutic or preventive agent for nausea/vomiting
TW200633721A (en) * 2004-12-14 2006-10-01 Shionogi & Co A pharmaceutical composition for treating constipation
CN101355943A (zh) * 2005-10-11 2009-01-28 东丽株式会社 呕气和/或呕吐治疗药
JPWO2008001859A1 (ja) * 2006-06-30 2009-11-26 学校法人北里研究所 オピオイドδ受容体アゴニスト

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
AU7631991A (en) * 1991-04-30 1992-11-26 Ur Labs, Inc. Method for reducing emesis and nausea induced by the administration of an emesis-causing agent
AU639053B2 (en) * 1989-11-28 1993-07-15 Toray Industries, Inc. Immunosuppressant and process for preparing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4613668A (en) * 1983-12-22 1986-09-23 The United States Of America As Represented By The Department Of Health And Human Services Short total synthesis or morphinan compounds which uses cyclization of a cycloalkylcarbonyl compound selected from cyclopropylcarbonyl and cyclobutylcarbonyl
PT95069B (pt) * 1989-08-24 1997-10-31 Searle & Co Processo para a preparacao de (+)-isomeros de derivados de endoetano/endoetanoepoximofinano, uteis como agentes anti-tussicos
JPH04342529A (ja) * 1991-05-21 1992-11-30 Toray Ind Inc 抗アレルギー剤

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816586A (en) * 1987-07-29 1989-03-28 Regents Of The University Of Minnesota Delta opioid receptor antagonists
AU639053B2 (en) * 1989-11-28 1993-07-15 Toray Industries, Inc. Immunosuppressant and process for preparing the same
AU7631991A (en) * 1991-04-30 1992-11-26 Ur Labs, Inc. Method for reducing emesis and nausea induced by the administration of an emesis-causing agent

Also Published As

Publication number Publication date
US5714483A (en) 1998-02-03
EP0636371A1 (en) 1995-02-01
DE69318710T2 (de) 1998-09-10
CA2130457A1 (en) 1994-07-07
KR950700065A (ko) 1995-01-16
EP0636371A4 (enExample) 1995-03-01
WO1994014445A1 (fr) 1994-07-07
NO943070L (no) 1994-10-21
CN1099617A (zh) 1995-03-08
DE69318710D1 (en) 1998-06-25
TW366284B (en) 1999-08-11
NO943070D0 (no) 1994-08-19
NO307496B1 (no) 2000-04-17
ATE166229T1 (de) 1998-06-15
AU5715694A (en) 1994-07-19
EP0636371B1 (en) 1998-05-20
CN1071117C (zh) 2001-09-19

Similar Documents

Publication Publication Date Title
CA2259148A1 (en) Solid oral dosage forms of valsartan
AU2300699A (en) Amidino derivatives and drugs containing the same as the active ingredient
CA2086974A1 (en) R(+)-terazosin
EP0645136A3 (en) Pharmaceutical preparation of the type: physiologically active substance with sustained release.
AU6062590A (en) Pharmaceutically active compounds
RU95101048A (ru) Производные пролинамида, фармкомпозиция на их основе
CA2163003A1 (en) Solubilizer and external preparations containing the same
AU7177794A (en) Absorption enhancers for drug administration
AU2002238947A1 (en) Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
EP0497258A3 (en) Use of adenosine antagonists in the prevention and treatment of pancreatitis and ulcer
AU3354895A (en) Novel medicinal use of 5ht3 antagonist
WO2000041681A3 (de) ARZNEIFORMULIERUNGEN ENTHALTEND EIN OPIOID UND EINEN α-AGONISTEN
AU3045292A (en) Active oxygen scavenger
TW221441B (enExample)
AU1792492A (en) Phellodendrine analogs and allergy type iv suppressor containing the same as active ingredient
AU5715694A (en) Antitussive
ATE128363T1 (de) Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
CA2064373A1 (en) Piperidine derivatives
AU1650401A (en) Oxadiazole derivatives and drugs containing these derivatives as the active ingredient
DE59001121D1 (en) Antacidatabletten.
ZA927506B (en) New drug formulation.
ZA981430B (en) Anticancer composition
AU3070192A (en) Uses of 1,1,1,3,3,3-hexafluoropropane
EP0509098A4 (en) Ataractic
AU3030392A (en) Pharmacologically active tricyclic derivatives

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired